Antibiotice Iasi | Romania Feed
"Antibiotice Iasi" in Romania feed
-
ZF English - 07:59 Aug 14, 2025
Generic drug manufacturer Antibiotice Iasi, controlled by the Romanian state via the Health Ministry, ended the first six months of 2025 with RON59 million net profit, down 20% from the year-earlier period. -
ZF English - 12:02 Jul 07, 2025
Privately managed pension fund Metropolitan Life now owns more than 5% in pharmaceutical producer Antibiotice Iasi (ATB.RO), a mark it overshot on July 1, when its stake increased to 5.034% or almost 34 million shares, Antibiotice said in a report to the Bucharest Stock Exchange on Monday. -
ZF English - 16:03 Jun 05, 2025
State-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) has announced in a stock market report on June 5 that it recently won the 5th tender organized by the National Health Service (NHS), the UK healthcare system. -
ZF English - 07:12 May 14, 2025
Pharma producer Antibiotice Iasi in the first quarter of this year generated total revenues of RON180 million, down 6%, and net profit of RON32.6 million, 13% lower than the year-earlier level. -
ZF English - 08:14 Feb 26, 2025
Romanian drug manufacturer Antibiotice Iasi in 2024 registered total revenues worth RON693 million, up 8%, and RON99 million net profit, 23% above the 2023 level. -
ZF English - 21:54 Feb 28, 2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with calculations by Ziarul Financiar (ZF) daily based on data from the company's annual preliminary financial report published at the Bucharest Stock Exchange. -
ZF English - 11:22 Aug 27, 2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held drug maker, on Friday reported on the Bucharest Stock Exchange that regional investment fund SIF Oltenia (SIF5) bought 18 million of its shares, for RON0.59 per unit, on August 25, 2021 . -
ZF English - 07:35 May 12, 2021
Antibiotice Iasi (ATB.RO), the largest Romanian-held pharmaceutical producer, on Wednesday reported sales of RON66.1 million for the first quarter of 2021, down 10.2% on the year, and a net profit of RON4.03 million, which is close to the level reported in the same period in 2020. -
ZF English - 15:22 Apr 14, 2021
Romanian state-owned Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, said in a stock market report on Wednesday that regional investment fund SIF Oltenia (SIF5.RO) reached the 23.07% threshold of Antibiotice Iasi’s share capital following a transaction held on April 12, 2021. -
ZF English - 14:41 Oct 16, 2020
Antibiotice Iasi (ATB.RO), the largest pharmaceutical producer in Romania, has won a tender held by the European Commission to supply necessary stock for the second wave of the Covid pandemic.